When was TwoStep Therapeutics founded?

TwoStep Therapeutics was founded in 2024 and raised its 1st funding round within a year of its incorporation.

Where is TwoStep Therapeutics located?

TwoStep Therapeutics is headquartered in San Carlos, United States.

Who is the current CEO of TwoStep Therapeutics?

Caitlyn Miller of TwoStep Therapeutics. They have also founded 1 company.

How many employees does TwoStep Therapeutics have?

As of Aug 31, 2026, the latest employee count at TwoStep Therapeutics is 10.

Is TwoStep Therapeutics a funded company?

TwoStep Therapeutics is a funded company, having raised a total of $71.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 25, 2024.

When was the latest funding round of TwoStep Therapeutics?

TwoStep Therapeutics' latest funding was a $***** Series A round on Jan 09, 2026, with participation from 7 investors.

Where does TwoStep Therapeutics rank among its competitors?

TwoStep Therapeutics ranks 882nd amongst 3304 active competitors, of which 1117 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of TwoStep Therapeutics?

TwoStep Therapeutics' top competitors include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

TwoStep Therapeutics - 2026 Company Profile, Team, Funding & Competitors

TwoStep Therapeutics is a series A company based in San Carlos (United States), founded in 2024 by Jennifer Cochran, Carolyn Bertozzi, Caitlyn Miller and Ronald Levy. It operates as a Developer of targeted cancer therapies focusing on solid tumors. TwoStep Therapeutics has raised $71.2M in funding from 2048 Ventures. The company has 3304 active competitors, including 1117 funded and 780 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.

Company Details

Developer of targeted cancer therapies focusing on solid tumors. The company uses a multi-targeting platform based on a Polyspecific Integrin-binding Peptide to create targeted cancer therapies for drug delivery and radioligand therapy.

Website: twosteptx.com
Social
Email ID: *****@twosteptx.com

Key Metrics

Founded Year

2024

Location

San Carlos, United States

Stage

Series A

Total Funding

$71.2M in 2 rounds

Latest Funding Round

Series A, Jan 09, 2026, $*****

Investors

2048 Ventures & 2 more

Ranked

882^nd among 3304 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

Jazz Pharmaceuticals & 2984 more

View TwoStep Therapeutics' full profile

TwoStep Therapeutics has raised a total funding of $71.2M over 2 rounds. Its first funding round was on Jun 25, 2024. Its latest funding round was a Series A round on Jan 09, 2026 for $*****. 7 investors participated in its latest round. TwoStep Therapeutics has 3 institutional investors.

Here is the list of recent funding rounds of TwoStep Therapeutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 09, 2026	1911690	Series A	2191759	5730803	4336060	8277560
Jun 25, 2024	3635320	Seed	3107211	2737559	2048 Ventures	NFX & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of TwoStep Therapeutics's funding rounds and investors

The founders of TwoStep Therapeutics are Jennifer Cochran, Carolyn Bertozzi, Caitlyn Miller and Ronald Levy. Caitlyn Miller is the CEO of TwoStep Therapeutics.

Here are the details of TwoStep Therapeutics' key team members:

Jennifer Cochran: Co-Founder of TwoStep Therapeutics.
Contact Info: 1 email address
Carolyn Bertozzi: Co-Founder of TwoStep Therapeutics.
Contact Info: 1 email address
Caitlyn Miller: Co-Founder & CEO of TwoStep Therapeutics.
Contact Info: 1 email address
Ronald Levy: Co-Founder of TwoStep Therapeutics.
Contact Info: 1 email address

View details of TwoStep Therapeutics's Founder profiles and Board Members

TwoStep Therapeutics' employee count trend

TwoStep Therapeutics has 10 employees as of Aug 26. Here is TwoStep Therapeutics's employee count trend over the years:

Employee count trend for TwoStep Therapeutics

Uncover TwoStep Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TwoStep Therapeutics include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of TwoStep Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	80/100
3rd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 18 others	74/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
9th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
882nd	TwoStep Therapeutics 2024, San Carlos (United States), Series A	Developer of targeted cancer therapies focusing on solid tumors	$71.2M	NFX, Alexandria Venture Investments & 1 others	45/100